PCM
MRK icon

Payne Capital Management’s Merck MRK Stock Holding History

Payne Capital Management’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.64M Sell
12,775
-1,000
-7% -$117K 0.44% 29
2026
Q1 		$1.66M Sell
13,775
-49
-0.4% -$5.66K 0.5% 26
2025
Q4 		$1.46M Buy
13,824
+37
+0.3% +$3.47K 0.46% 28
2025
Q3 		$1.16M Buy
13,787
+9,682
+236% +$797K 0.37% 31
2025
Q2 		$325K Buy
4,105
+1,576
+62% +$125K 0.13% 54
2025
Q1 		$227K Sell
2,529
-562
-18% -$52.5K 0.1% 63
2024
Q4 		$307K Buy
+3,091
New +$319K 0.13% 51

Other funds holding MRK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Payne Capital Management's MRK Position: Q2 2026 in Review

Payne Capital Management reduced its Merck (MRK) stake by 7.3% in Q2 2026, selling an estimated $117K and leaving 12,775 shares worth $1.64M. The position accounts for 0.44% of the portfolio, ranked #29.

Payne Capital Management first reported a position in MRK in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.66M in Q1 2026. 3,813 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Payne Capital Management held 12,775 shares of Merck worth $1.64M as of Q2 2026.
  • Payne Capital Management sold 1,000 Merck shares in Q2 2026, an estimated $117K.
  • Merck made up 0.44% of Payne Capital Management's portfolio in Q2 2026, its #29 holding.
  • Payne Capital Management first reported a position in Merck in Q4 2024 and has held it in 7 quarters since.
  • Payne Capital Management's Merck position peaked at $1.66M in Q1 2026.
  • 3,813 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Payne Capital Management's 13F filing for Q2 2026, filed 17 Aug 2026.